Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Volitionrx Ltd
(NY:
VNRX
)
0.5990
-0.0111 (-1.82%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Volitionrx Ltd
< Previous
1
2
3
Next >
VolitionRX Earnings Perspective: Return On Capital Employed
September 24, 2021
According to Benzinga Pro data, during Q2, VolitionRX (AMEX:VNRX) posted sales of $24.78 thousand. Earnings were up 3.03%, but VolitionRX still reported an overall loss of $5.90...
Via
Benzinga
VolitionRX Ltd (VNRX) Q2 2021 Earnings Call Transcript
August 12, 2021
VNRX earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Earnings Scheduled For August 11, 2021
August 11, 2021
Companies Reporting Before The Bell • Wireless Telecom Group (AMEX:WTT) is likely to report earnings for its second quarter. • Gamida Cell (NASDAQ:GMDA) is...
Via
Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
Exposures
Product Safety
Earnings Scheduled For May 11, 2021
May 11, 2021
Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter. • ReWalk Robotics (NASDAQ:RWLK) is...
Via
Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...
Via
Benzinga
Exposures
Product Safety
Looking Into VolitionRX's Return On Capital Employed
June 18, 2021
In Q1, VolitionRX (AMEX:VNRX) posted sales of $25.53 thousand. Earnings were up 7.53%, but VolitionRX still reported an overall loss of $6.09 million. In Q4, VolitionRX brought in...
Via
Benzinga
Looking Into VolitionRX's Return On Capital Employed
June 04, 2021
During Q1, VolitionRX's (AMEX:VNRX) reported sales totaled $25.53 thousand. Despite a 7.53% in earnings, the company posted a loss of $6.09 million. VolitionRX collected $7.12...
Via
Benzinga
Volition Rx Limited (VNRX) Q1 2021 Earnings Call Transcript
May 12, 2021
VNRX earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
May 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.